feed,title,long_url,short_url
Benzinga,Analyst Cuts Price On Travere Therapeutics Citing Expected Delayed PDUFA,https://benzinga.com/general/biotech/22/10/29271600/analyst-cuts-price-on-travere-therapeutics-citing-expected-delayed-pdufa,https://bit.ly/3rWPc9e
Benzinga,Analyst Attributes Two Issues For Owens & Minor's Shares Sell Off,https://benzinga.com/news/22/10/29271248/analyst-attributes-two-issues-for-owens-minors-shares-sell-off,https://bit.ly/3ENnQdz
